Assessing the Safety of Buprenorphine in People With Sickle Cell Disease
Status:
Active, not recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
This study will assess the safety of changing pain medications (opioids) adult sickle cell
patients take to another type of medication therapy (buprenorphine). Patients will be asked
questions about their quality of life. Other tools for assessment will also be administered.